Strategic Analysis of Sleep Apnea Diagnostic and Sleep Services Market in Europe

Transcription

1 Strategic Analysis of Sleep Apnea Diagnostic and Sleep Services Market in Europe Favorable Market Dynamics and Product Alternatives are Driving the Market to New Heights M February 2012

2 Contents Executive Summary 5 Research Scope and Methodologies 11 Total Sleep Apnea Diagnostics and Sleep Services Market in Europe 15 Market Definition 16 Market Segmentation 17 Market Engineering Measurement 18 Industry Challenges 19 Market Dynamics Drivers and Restraints 20 Revenue Forecast 28 Total Sleep Apnea Diagnostics and Sleep Services Market Analysis 33 Demand Analysis 34 Market and Technology Trends 35 Pricing Trends 36 Competitive Landscape 37 Competitive Structure 38 Competitor Overview 39 M

3 Contents (continued) Geographic Analysis 40 Geographic Region Analysis of the Total Market 41 Forecast by Geographic Region 42 Regional Hot Spots 43 Sleep Apnea Diagnostics and Sleep Services Market By Region 44 Germany 45 France 54 The United Kingdom 63 Italy 72 Spain 81 Benelux 90 Scandinavia 99 M

4 Contents (continued) Conclusion Appendix The Frost & Sullivan Story 117 M

5 Market Overview The market for sleep apnea diagnostics and sleep services in Europe is gaining momentum mainly due to the growing drive to improve public awareness about the ill effects of sleep disorders and their relation to other chronic health issues. Various organizations, including the World Sleep Foundation and the European Sleep Research Society, have contributed significantly to these awareness campaigns. Similarly, individual countries have independent sleep research organizations that aim to create awareness and to increase the demand for research and development in order to improve technological advancement in treating sleep disorders. The sleep apnea diagnostics and sleep services market in Europe recorded revenue worth $xxx.x million in xx.x percent of these revenue were generated by the sale of Clinical PSGs, and xx.x percent of the market revenue were contributed by Ambulatory PSGs. Screening Devices contributed to x.x percent of the market revenue in Europe in The overall market for sleep apnea diagnostics and sleep services in Europe is estimated to grow at a CAGR of x.x percent between 2010 and The majority of this growth is expected to be driven by the growth of the ambulatory segment in which many service providers and device manufacturers are investing time and money to support the usage of ambulatory devices in order to reduce the huge waiting lists in all sleep centers that are dependent on clinical PSGs. M

6 Market Scope Market Classification Total Sleep Apnea Diagnostic and Sleep Services Market: Sleep Apnea Etiologies, Europe, 2010 Devices Services Asthma Depression Clinical PSG Hospital Based Sleep Labs Geriatrics Narcolepsy Cardiovascular Diseases Ambulatory PSG Non-Hospital Based Sleep Labs Diabetes Airway Resistance Syndrome Sleep Apnea Pregnancy Cerebrovascular Diseases Screening Devices Obesity This study deals with assessing the diagnostic devices used in examining a person who is likely to be suffering from sleep apnea. It analyzes the above mentioned devices and the services rendered by both hospital and non-hospital based sleep labs that conduct studies using the devices mentioned above. M

7 Major Research Findings The European sleep apnea diagnostics market is expected to witness a fall in prices during the period between 2011 and The diagnostics devices market witnessed a gradual increase in revenue due to increased demand stimulated by improved awareness. On average, every sleep lab (both hospital and non-hospital based) uses about 3 to 4 clinical PSG units and about 2 ambulatory PSG units. Other screening devices comprise roughly 1/4th of the devices installed in a single sleep lab. Probabilities considered during the forecast include the zero refurbishment market for diagnostics and the therapeutic devices market. Growing awareness, coupled with an increasing number of patients suffering from sleep disorders, is stimulating the current market revenue growth. Simultaneously, factors such as inconsistent reimbursement policies and a lack of certified technicians in a few European countries are hampering a potential market expansion. M

8 Market Analysis Hospital-based sleep labs refer to sleep centers or clinics that are housed in a hospital. These are expected to grow rapidly in number due to the reliability of studies performed in hospital based labs. Home based sleep centers, which are one portion of the non-hospital based sleep labs, conduct studies but have not been able to gain significant prominence thus far because the public is still reluctant to place its confidence in the results produced by home based devices. But the scenario stands to change, as there is improved technological advancement and a growing need from children below the age of xx who suffer from sleep disorders. Children are generally diagnosed and treated at home to avoid putting pressure on them by having them examined at a hospital. Rapidly improving technologies, especially in the area of remote monitoring, is helping this segment to grow and is also addressing the challenge of the shortage of technicians. M

9 Conclusions and Recommendations R&D investment is holding the key to success in the European market for sleep apnea diagnostics and sleep services. The industry must focus on quality research and development approaches to bring forth innovative products for out-of-lab diagnoses that are cost-effective. This will help to meet the screening demands of the masses, cut short the waiting lists at the sleep clinics and increase market penetration. Increase the focus on ambulatory PSGs in order to bring about the reliability of result produced through such studies. This will address the long waiting lists and limited funding. Less valuable options, such as ambulatory PSG, will help to increase the awareness levels, as well. Efficient after sales support and service will help with gaining credibility amongst users and help with improving the market revenue. Uninterrupted technical support by the vendors, with a sufficient amount of qualified personnel, should be made available in order to increase brand reliability. Interdisciplinary studies are demanding non-independent data management software, because results from PSG can be integrated into one system to provide the most effective data. This will demand mutual alliances or partnerships with equipment manufacturers in order to create comprehensive solutions and systems. It is imperative to design adequate strategies to increase and simplify diagnosis and to provide costeffective solutions that justify the investment. It is important to increase the resources to capitalize on the market potential and the current requirements of the population. M